.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Covington
Chinese Patent Office
Fish and Richardson
Argus Health
Deloitte
Baxter
Healthtrust
Cerilliant

Generated: September 19, 2017

DrugPatentWatch Database Preview

Pentobarbital - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pentobarbital and what is the scope of pentobarbital patent protection?

Pentobarbital
is the generic ingredient in four branded drugs marketed by Oak Pharms, Purepac Pharm, Sagent Pharms, Lannett, Whiteworth Town Plsn, Nexgen Pharma Inc, Wyeth Ayerst, Parke Davis, Everylife, Perrigo, Ivax Sub Teva Pharms, Valeant Pharm Intl, Elkins Sinn, Halsey, Vitarine, Anabolic, and Watson Labs, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for pentobarbital.

Summary for Generic Name: pentobarbital

Tradenames:4
Patents:0
Applicants:17
NDAs:26
Drug Master File Entries: see list2
Bulk Api Vendors: see list23
Clinical Trials: see list7
Patent Applications: see list7,250
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:pentobarbital at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Oak Pharms
NEMBUTAL
pentobarbital sodium
SUPPOSITORY;RECTAL083247-001Jan 25, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083461-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083301-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Valeant Pharm Intl
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083264-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Everylife
SODIUM PENTOBARBITAL
pentobarbital sodium
CAPSULE;ORAL083259-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL SODIUM
pentobarbital sodium
CAPSULE;ORAL084093-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL
pentobarbital sodium
SUPPOSITORY;RECTAL083247-004Jan 25, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Wyeth Ayerst
SODIUM PENTOBARBITAL
pentobarbital sodium
INJECTABLE;INJECTION083261-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Vitarine
PENTOBARBITAL SODIUM
pentobarbital sodium
CAPSULE;ORAL083284-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Oak Pharms
NEMBUTAL
pentobarbital sodium
SUPPOSITORY;RECTAL083247-002Jan 25, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Baxter
Daiichi Sankyo
McKesson
Dow
Colorcon
Cantor Fitzgerald
Novartis
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot